GLITOS 15 pioglitazone (as hydrochloride) 15mg tablet blister pack

Land: Australien

Sprache: Englisch

Quelle: Department of Health (Therapeutic Goods Administration)

Wirkstoff:

pioglitazone hydrochloride, Quantity: 16.536 mg (Equivalent: pioglitazone, Qty 15 mg)

Verfügbar ab:

Arrotex Pharmaceuticals Pty Ltd

INN (Internationale Bezeichnung):

Pioglitazone hydrochloride

Darreichungsform:

Tablet

Zusammensetzung:

Excipient Ingredients: carmellose calcium; hyprolose; magnesium stearate; lactose monohydrate

Verabreichungsweg:

Oral

Einheiten im Paket:

50 tablets, 7 tablets, 28 tablets, 98 tablets

Verschreibungstyp:

(S4) Prescription Only Medicine

Anwendungsgebiete:

Treatment of type 2 diabetes inadequately controlled by diet and exercise: ? As monotherapy ? As dual therapy to improve glycaemic control - In combination with metformin or sulfonylurea - In combination with insulin ? As triple therapy to improve glycaemic control - In combination with metformin and sulfonylurea

Produktbesonderheiten:

Visual Identification: White to off white, round, flat faced beveled edge uncoated tablets debossed with '140' on one side and '15' on the other side; Container Type: Blister Pack; Container Material: PVC/PVDC/PE; Container Life Time: 2 Years; Container Temperature: Store below 30 degrees Celsius

Berechtigungsstatus:

Licence status A

Berechtigungsdatum:

2011-10-26